Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Social Phobia
Interventions
DRUG

AV608

Trial Locations (15)

10024

Medical Research Network, LLC, New York

20852

DuPont Clinical Research, Inc., Rockville

32216

CNS Healthcare, Jacksonville

33613

University of South Florida, Tampa

33702

Comprehensive Neuroscience, Inc., St. Petersburg

35216

Birmingham Research Group, Inc., Birmingham

45242

Hartford Research, Cincinnatti

73130

IPS Research Company, Oklahoma City

77401

Claghorn-Lesem Research Clinic, LLP, Bellaire

78229

Croft Group Research Center, San Antonio

85210

Pivotal Research Centers, Mesa

90210

Southwestern Research, Inc., Beverly Hills

92108

Affiliated Research Institute, San Diego

97210

Summit Research Network, Portland

Unknown

Capital Clinical Research Associates, Rockville

Sponsors
All Listed Sponsors
lead

Avera Pharmaceuticals

INDUSTRY

NCT00294346 - Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder | Biotech Hunter | Biotech Hunter